Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL988700 | 0.81 | LMNA (0.33) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8733759 | 0.71 | — | — | |
| SCHEMBL890999 | 0.70 | XIAP (0.39) | — | |
| SCHEMBL4384017 | 0.70 | NPSR1 (0.33) | — | |
| SCHEMBL2126262 | 0.67 | MAPT (0.31) | — | |
| Triethylene Glycol SCHEMBL5699200 | 0.64 | MEN1 (0.46) | — | |
| SCHEMBL17226003 | 0.62 | — | — | |
| SCHEMBL8333111 | 0.62 | GSK3B (0.58) | — | |
| SCHEMBL29150779 | 0.61 | TP53 (0.43) | — | |
| SCHEMBL9491519 | 0.58 | XIAP (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10989651-B2 | Molecular detection system | THE UNIVERSITY OF BIRMINGHAM (GB) | 2021-04-27 | — | — | US | disclosed |
| EP-3703666-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | Universidade de Santiago de Compostela (ES) | 2020-09-09 | — | — | EP | disclosed |
| CN-110204478-A | Carbonic anhydrase targeting agent and its application method | 文森医学公司 | 2019-09-06 | — | — | CN | disclosed |
| EP-3149451-B1 | IMPROVED MOLECULAR DETECTION SYSTEM | UNIV BIRMINGHAM (GB) | 2019-02-20 | — | — | EP | disclosed |
| CN-104955484-B | Prostate-specific antigen medicament and its application method for prostate cancer imaging | 文森医学公司 | 2019-01-15 | — | — | CN | disclosed |
| US-20170191927-A1 | IMPROVED MOLECULAR DETECTION SYSTEM | THE UNIVERSITY OF BIRMINGHAM (GB) | 2017-07-06 | — | — | US | disclosed |
| EP-3149451-A1 | IMPROVED MOLECULAR DETECTION SYSTEM | The University Of Birmingham (GB) | 2017-04-05 | — | — | EP | disclosed |
| US-20160368993-A1 | ALPHA-V BETA-6 INTEGRIN-BINDING ANTIBODY FRAGMENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-12-22 | — | — | US | disclosed |
| WO-2015181546-A1 | IMPROVED MOLECULAR DETECTION SYSTEM | THE UNIVERSITY OF BIRMINGHAM (GB) | 2015-12-03 | — | — | WO | disclosed |
| US-9175036-B2 | Antimicrobial water treatment membranes and production thereof | BEN-GURION UNVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2015-11-03 | — | — | US | disclosed |
| EP-1535952-B1 | Method for preparing crosslinked polyelectrolyte multilayer films | UNIV PASTEUR (FR) | 2013-01-16 | — | — | EP | disclosed |
| US-20120325748-A1 | ANTIMICROBIAL WATER TREATMENT MEMBRANES AND PRODUCTION THEREOF | BAR-ILAN UNIVERSITY (IL) | 2012-12-27 | — | — | US | disclosed |
| WO-2012172547-A1 | IMMOBILIZATION OF ANTIMICROBIAL POLYMERS ON RO MEMBRANE TO REDUCE BIOFILM GROWTH AND BIOFOULING | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2012-12-20 | — | — | WO | disclosed |
| EP-2509614-A1 | ANTIMICROBIAL WATER TREATMENT MEMBRANES AND PRODUCTION THEREOF | Ben-Gurion University Of The Negev Research And Development Authority (IL) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011070573-A1 | ANTIMICROBIAL WATER TREATMENT MEMBRANES AND PRODUCTION THEREOF | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2011-06-16 | — | — | WO | disclosed |
| US-20070129792-A1 | Method for preparing crosslinked polyelectrolyte multilayer films | INSERM ( INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2007-06-07 | — | — | US | disclosed |
| CN-1307263-C | Fluorescent dye, method and kit for saturation labeling of proteins | AMOSEN BIOLOG SCIENCE BRITISH (GB) | 2007-03-28 | — | — | CN | disclosed |
| CN-1650168-A | Reagents and methods for saturation labelling of proteins | AMOSEN BIOLOG SCIENCE BRITISH (GB) | 2005-08-03 | — | — | CN | disclosed |
| WO-2005052035-A1 | METHOD FOR PREPARING CROSSLINKED POLYELECTROLYTE MULTILAYER FILMS | UNIVERSITE LOUIS PASTEUR (FR) | 2005-06-09 | — | — | WO | disclosed |
| EP-1535952-A1 | Method for preparing crosslinked polyelectrolyte multilayer films | UNIVERSITE LOUIS PASTEUR (FR) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120325748-A1 | ANTIMICROBIAL WATER TREATMENT MEMBRANES AND PRODUCTION THEREOF | AQP1, VIP, AQP3 | GRIN2D 4296/4885GRIN3B 4132/4885GRIN1 4122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.